…tive explanation for her symptoms, including conditions such as multiple sclerosis, CNS lymphoma, vasculitis or paraneoplastic syndromes. Despite …
multiple myeloma
This disease is selected. Its supporting articles are shown below.
Articles mentioning multiple myeloma
44 articles · page 2 of 4…-phase development to practice-changing trials, particularly in prostate cancer and neuroendocrine tumours. 51 In prostate cancer, the phase II…
… cells to CD1d-expressing hematological malignancies, including multiple myeloma (MM) and acute myeloid leukemia (AML). Here, we evaluated wheth…
…d producing type I interferons, but is frequently suppressed in multiple myeloma (MM), enabling immune evasion. Dexamethasone (DXM), a cornersto…
…Background CD70, overexpressed in multiple myeloma (MM), is a promising target for theranostics. This study develo…
… was instituted to monitor disease recurrence or progression to multiple myeloma.…
…sions CD74 contributes to immune escape and CAR-T resistance in R/R MM. Therapeutic targeting of CD74 enhances BCMA CAR-T efficacy and…
… Belantamab-mafodotin (Belamaf, GSK) is a 2nd line biologic for multiple myeloma which has been recently approved by NICE in the UK and FDA in t…
… a known teratogen, licensed in the UK for treating adults with multiple myeloma. 1 2 Despite its severe teratogenic potential, it is also used …
…moderate validity in AL (r=0.386, p=0.002) and poor validity in lymphoma (r=0.230, p=0.129). In patients with AL, chronic kidney failure…
…myeloma cells, used in relapsed or refractory multiple myeloma (RRMM). While pivotal trials have shown promising results, real-world…
…s for transplant-ineligible (TIE) patients with newly diagnosed multiple myeloma (NDMM).Aim and Objectives This study aimed to evaluate the real…